LYNDRA THERAPEUTICS
Lyndra Therapeutics is reinventing medicines to make daily pills a thing of the past, replacing them with its oral, ultra-long-acting, sustained-release therapies. Administering and conveniently distributing medicines in weekly or longer-term doses – including using polypill approaches – will improve safety, efficacy, and adherence to maximize global health impact and lower overall healthcare costs.
LYNDRA THERAPEUTICS
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2015-01-14
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.lyndra.com
Total Employee:
11+
Status:
Active
Contact:
+1-857-304-4512
Email Addresses:
[email protected]
Total Funding:
163.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Current Advisors List
Current Employees Featured
Founder
Investors List
AIG Investments
AIG Investments investment in Series C - Lyndra Therapeutics
Limitless Ventures
Limitless Ventures investment in Series C - Lyndra Therapeutics
Gilead Sciences
Gilead Sciences investment in Series C - Lyndra Therapeutics
ImpactAssets
ImpactAssets investment in Series C - Lyndra Therapeutics
Quark Venture
Quark Venture investment in Series C - Lyndra Therapeutics
Yipinhong Pharmacy
Yipinhong Pharmacy investment in Series C - Lyndra Therapeutics
THE CATALYTIC IMPACT FOUNDATION (CIF)
THE CATALYTIC IMPACT FOUNDATION (CIF) investment in Series C - Lyndra Therapeutics
Polaris Partners
Polaris Partners investment in Series C - Lyndra Therapeutics
HOPU Investment Management Company
HOPU Investment Management Company investment in Series C - Lyndra Therapeutics
Mass General Brigham Ventures
Mass General Brigham Ventures investment in Series C - Lyndra Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-08 | Lyndra Therapeutics Appoints Klas Holmlund, CFA, as Chief Financial Officer |
Official Site Inspections
http://www.lyndra.com Semrush global rank: 3.54 M Semrush visits lastest month: 4.13 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Lyndra Therapeutics"
Home - Lyndra
Lyndra’s core purpose to reinvent medicine for a healthier world, coupled with its unique values and the exceptional people who live them every day, make Lyndra a distinctive company with …See details»
Research - Lyndra
Lyndra is reinventing medicine for a healthier world with the help of its partners and with funding support from organizations including the Bill & Melinda Gates Foundation, the National Institutes of Health and others.See details»
About - Lyndra
Meet the team behind Lyndra’s LYNX ® drug delivery platform. Lyndra Therapeutics is pioneering long-acting oral therapies, a potential major advance in oral drug delivery. Lyndra’s proprietary LYNX ® drug delivery platform is …See details»
Lyndra Therapeutics - Crunchbase Company Profile
Lyndra Therapeutics is a company that develops medicines for long-term drug release in an oral dose form. The company is developing oral ultra-long-acting and sustained-release therapies for central nervous system (CNS) disorders …See details»
Lyndra Therapeutics, Inc. | Re-Imagining TB Care
Lyndra is a private US-based specialty pharma company seeks to improve healthcare outcomes through oral, ultra-long-acting, sustained-release therapies that change how people take …See details»
Lyndra Therapeutics Announces Leadership Changes, Update on …
Jul 17, 2023 · Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra is focused on commercializing therapies in central nervous …See details»
Lyndra Therapeutics' Leadership Team - Team members and org …
The leadership team at Lyndra Therapeutics has a rich history of experience in the fields of medicine, engineering, business, and more. Many members of the team have worked for …See details»
Lyndra Therapeutics - The Org
Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather …See details»
For Patients - Lyndra
Lyndra’s LYNX ® drug delivery platform has the potential for broad applicability across multiple therapeutic areas – including approved drugs and those currently in development. Lyndra has assembled a visionary and determined team that …See details»
Weekly Pill Formulation Could Help Treat Schizophrenia, HIV, …
Jun 10, 2020 · The company is using the platform to develop ultra-long-acting medications that could enable patients to replace their daily drug regimens with taking a single pill once a week, …See details»
Lyndra Therapeutics Doses First Clinical Trial …
Jun 9, 2022 · WATERTOWN, Mass.-- ( BUSINESS WIRE )--Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the past, today announced it has dosed the first...See details»
Weekly Pill Formulation Could Help Treat Schizophrenia, HIV, …
Jun 10, 2020 · Lyndra Therapeutics, in Watertown, Massachusetts, has developed a new form of capsule that can release medication not over the course of a day, but over a week or longer.See details»
Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal ...
May 9, 2023 · Lyndra’s LYNXâ„¢ drug delivery platform is designed to enable a week-long dose of risperidone to be delivered in a single oral capsule. The oral daily form of risperidone is one of …See details»
Team - Lyndra
The members of the Lyndra team are engineers and designers, technologists and chemists, doctors and nurses, and people of many other backgrounds who have all come together to …See details»
Lyndra Therapeutics Raises $101 Million in Series E Funding
WATERTOWN, Mass., December 21, 2023 -- (BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical company, today announced the closing of a $101 million …See details»
Lyndra Therapeutics Presents Data on Long-Acting Oral Weekly ...
May 31, 2023 · Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra’s initial focus is on developing therapies in central nervous …See details»
Resources Archive - Lyndra
Jul 17, 2023 · Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective DisorderSee details»
Long-lasting oral therapy developer Lyndra secures a $101m Series E
Dec 22, 2023 · Lyndra develops its long-lasting oral therapies using its LYNX drug delivery platform spun out of MIT. According to the company, it creates medicines that last for a week …See details»
CNS Research - Lyndra
Jan 4, 2024 · Lyndra’s extended release drug delivery systems can increase adherence, prevent relapses and improve outcomes for people with CNS disorders.See details»
Lyndra Therapeutics Raises $101 Million in Series E Funding
Dec 21, 2023 · Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra’s LYNX ® drug delivery platform is one of the most …See details»